深圳市麻疹免疫效果及成本效益分析  

Analysis of Effect and Cost-benefit on Measles Vaccination in Shenzhen

作　　者：单芙香[1] 刘刚[1] 

机构地区：[1]深圳市疾病预防控制中心,广东深圳518020

出　　处：《实用预防医学》2008年第3期709-710,共2页Practical Preventive Medicine

基　　金：深圳市科技局科研立项基金

摘　　要：目的分析麻疹疫苗免疫的效果及其经济效益,为2012年实施麻疹消除策略提供依据。方法分析深圳市麻疹免疫的历年资料和免疫监测资料,采用成本-效益分析方法分析麻疹免疫的经济和社会效益。结果2004年监测结果显示,人群中麻疹抗体阳性率为83.6%,1983-2004年深圳市麻疹免疫投入成本为55088159元(2004年的贴现值),产出效益395538712元,净效益为340450553元,效益成本比为7.18,减少麻疹病人195376例。结论接种麻疹疫苗可产生巨大的经济效益和社会效益。Objective To analyze the effect and economic benefit of measles vaccination, and to provide scientific basis for eliminating measles in 2012. Methods The data of measles vaccination and immunization monitoring from 1980 to 2004 in Shenzhen were analyzed, and cost- benefit analysis method was used to analyze the economic and social benefits of measles vaccination. Results The results of measles surveillance in 2004 showed that the antibody positive rate was 83.6 % in population. Investment cost of measles vaccination from 1983 to 2004 was ￥55,088,159, product benefit was ￥ 395,538.712. net benefit was ￥340,450,553. and ratio of cost and benefit was 7.18 in Shenzhen. Social benefit analysis showed that 195,376 individuals avoided suffering from measles from 1983 to 2004. Conclusion Measles vaccination can bring enormous economic and social benefit.

关 键 词：麻疹疫苗 成本 效益 效益成本比 

分 类 号：R186[医药卫生—流行病学]